6862:HKEXHaidilao International Holding Ltd. Analysis
Data as of 2026-05-20 - not real-time
HK$14.27
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Haidilao is trading at HK$14.27, barely above its 20‑day SMA (HK$14.59) and just above a key support level around HK$13.82, while the 50‑day SMA remains higher at HK$15.09, suggesting limited upside momentum. Technical indicators show a bearish MACD crossover and a neutral RSI at 42, indicating neither strong oversold nor overbought conditions, but the recent increase in trading volume points to heightened market interest. Fundamentally, the company delivers robust profitability with a 39.6% ROE and a 9.4% profit margin, yet its price‑to‑book (6.9×) and price‑to‑earnings (16.6×) sit above peers, and the DCF‑derived fair value of HK$12.59 implies the stock is currently overvalued. The dividend yield is attractive at 5.07%, but a payout ratio exceeding 100% raises concerns about sustainability. Combined with a high 30‑day volatility of 36% and a low beta (~0.4), the stock presents a mixed risk profile amid a consumer‑cyclical sector sensitive to discretionary spending and regulatory scrutiny in China.
Given the overvaluation relative to intrinsic estimates, the strained dividend payout, and bearish short‑term technical signals, investors may consider a cautious stance. However, Haidilao’s strong cash generation, high ROE, and brand equity support a longer‑term view that could justify accumulation if the price corrects toward its fair value.
Given the overvaluation relative to intrinsic estimates, the strained dividend payout, and bearish short‑term technical signals, investors may consider a cautious stance. However, Haidilao’s strong cash generation, high ROE, and brand equity support a longer‑term view that could justify accumulation if the price corrects toward its fair value.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price hovering just above support with bearish MACD
- Overvaluation relative to DCF fair value
- High dividend payout ratio (>100%) questioning sustainability
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong ROE and cash flow generation
- Elevated valuation multiples but improving earnings outlook
- Continued exposure to consumer‑cyclical demand cycles
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- High return on equity and solid free cash flow
- Brand strength and franchise expansion potential
- Opportunity for price correction toward intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth5.90%
Profit Margin9.37%
P/E Ratio16.6
ROE39.58%
ROA14.61%
Debt/Equity59.31
P/B Ratio6.9
Op. Cash FlowHK$5.7B
Free Cash FlowHK$3.9B
Technical Analysis
TrendNeutral
RSI42.5
SupportHK$13.82
ResistanceHK$15.54
MA 20HK$14.59
MA 50HK$15.09
MA 200HK$14.51
MACDBearish
VolumeIncreasing
Fear & Greed Index90.25
Valuation
Fair ValueHK$12.59
Target PriceHK$17.80
Upside/Downside24.73%
GradeOvervalued
TypeBlend
Dividend Yield5.07%
Risk Assessment
Beta0.39
Volatility36.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.